Cohort (CHRT) Q4 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 TU earnings summary
27 May, 2026Executive summary
Revenue reached £303m and adjusted operating profit was approximately £36m, both ahead of market expectations for the year ended 30 April 2026.
Strong order intake of around £313m, exceeding in-year revenue, with a record closing order book of about £620m.
Communications and Intelligence division drove performance, notably with a full-year contribution from EM Solutions.
Net funds at year-end were £2.9m, reflecting a significant turnaround from a net debt position at the half-year.
Financial highlights
Revenue grew 12% year-over-year to £303m; adjusted operating profit was about £36m.
Net margin improved to 11.9% from 10.2% the previous year.
Closing net funds were £2.9m, down from £5.3m last year, but up from a net debt position at H1.
Order intake increased by 10% year-over-year, totaling £313m.
Outlook and guidance
Order book underpins approximately £253m of current market revenue expectations for the new financial year, providing about 80% cover.
Management expresses confidence in a strong 2026/27 financial year, supported by high order cover and a robust balance sheet.
Latest events from Cohort
- Growth in defence tech driven by acquisitions, innovation, and global expansion.CHRT
Investor presentation16 Mar 2026 - Record revenue and order book, strong global demand, and robust outlook drive confidence.CHRT
Investor Update3 Feb 2026 - Record results, robust order book, and strong demand support a positive growth outlook.CHRT
H2 20243 Feb 2026 - Acquisition brings new tech, global reach, and strong financial upside in defense markets.CHRT
M&A Announcement13 Jan 2026 - Record revenue, strong order book, and global demand drive positive outlook and margin growth.CHRT
Investor Update12 Jan 2026 - Record revenue, profit, and order book set strong foundation for continued growth.CHRT
H1 202511 Jan 2026 - Revenue up 9% to £128.8m, strong order book, and positive outlook for H2.CHRT
H1 202611 Dec 2025 - Record revenue, profit, and order book with strong outlook driven by global defense demand.CHRT
H2 202516 Nov 2025 - Record revenue and profit growth, strong order book, and higher dividend signal robust outlook.CHRT
H2 2025 Pre-Recorded16 Nov 2025